SPORE Core Director Awarded NIH R01

Congratulations to Ryan Fields, MD, the SPORE Biospecimen Core Director, on his recent R01 award from the National Institutes of Health for his project titled “Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model”. In collaboration with his co-investigators in the Department of Immunology, including SPORE Co-Investigator R. Schreiber, the McDonnell Genome Institute, Yale University, and The Jackson Laboratory, this award of $2.2 million over three years will be used to model human cancers in the context of an autologous competent immune system.

Dr. Fields research interests lie in the care of patients with tumors of the pancreas, liver (primary and metastatic), bile ducts, stomach and small intestine, as well as patients with melanoma and other skin cancers and sarcomas. His research focuses on the identification and treatment of patients at high risk for recurrence of their cancer and the use of novel treatment modalities to improve survival.